finance.yahoo.com
CVS Health's Price Target Increased to $74 Amid Positive Outlook on Medicare Advantage Recovery
816+ Words Refined into 4 Facts by AI • 1 source • 2m ago
Show Full Summary
- Analyst Ben Hendrix raised CVS Health's price target to $74.
- Management is confident in long-term Medicare Advantage margin recovery.
- Stabilized MA utilization and disciplined pricing could enhance earnings.
- RBC Capital believes CVS could exceed consensus estimates in future.
The sources of this summary are listed below. Click to view.